129 related articles for article (PubMed ID: 32521546)
1. Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion.
Petignot S; Daly AF; Castermans E; Korpershoek E; Scagnol I; Beckers P; Dideberg V; Rohmer V; Bours V; Beckers A
Horm Metab Res; 2020 Nov; 52(11):784-787. PubMed ID: 32521546
[TBL] [Abstract][Full Text] [Related]
2. Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?
Seabrook AJ; Harris JE; Velosa SB; Kim E; McInerney-Leo AM; Dwight T; Hockings JI; Hockings NG; Kirk J; Leo PJ; Love AJ; Luxford C; Marshall M; Mete O; Pennisi DJ; Brown MA; Gill AJ; Hockings GI; Clifton-Bligh RJ; Duncan EL
J Clin Endocrinol Metab; 2021 Mar; 106(4):1163-1182. PubMed ID: 33367756
[TBL] [Abstract][Full Text] [Related]
3. Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis.
Korpershoek E; Koffy D; Eussen BH; Oudijk L; Papathomas TG; van Nederveen FH; Belt EJ; Franssen GJ; Restuccia DF; Krol NM; van der Luijt RB; Feelders RA; Oldenburg RA; van Ijcken WF; de Klein A; de Herder WW; de Krijger RR; Dinjens WN
J Clin Endocrinol Metab; 2016 Feb; 101(2):453-60. PubMed ID: 26670126
[TBL] [Abstract][Full Text] [Related]
4. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
Burnichon N; Cascón A; Schiavi F; Morales NP; Comino-Méndez I; Abermil N; Inglada-Pérez L; de Cubas AA; Amar L; Barontini M; de Quirós SB; Bertherat J; Bignon YJ; Blok MJ; Bobisse S; Borrego S; Castellano M; Chanson P; Chiara MD; Corssmit EP; Giacchè M; de Krijger RR; Ercolino T; Girerd X; Gómez-García EB; Gómez-Graña A; Guilhem I; Hes FJ; Honrado E; Korpershoek E; Lenders JW; Letón R; Mensenkamp AR; Merlo A; Mori L; Murat A; Pierre P; Plouin PF; Prodanov T; Quesada-Charneco M; Qin N; Rapizzi E; Raymond V; Reisch N; Roncador G; Ruiz-Ferrer M; Schillo F; Stegmann AP; Suarez C; Taschin E; Timmers HJ; Tops CM; Urioste M; Beuschlein F; Pacak K; Mannelli M; Dahia PL; Opocher G; Eisenhofer G; Gimenez-Roqueplo AP; Robledo M
Clin Cancer Res; 2012 May; 18(10):2828-37. PubMed ID: 22452945
[TBL] [Abstract][Full Text] [Related]
5. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
[TBL] [Abstract][Full Text] [Related]
6. Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumours.
Flynn A; Dwight T; Benn D; Deb S; Colebatch AJ; Fox S; Harris J; Duncan EL; Robinson B; Hogg A; Ellul J; To H; Duong C; Miller JA; Yates C; James P; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
J Pathol; 2017 Jul; 242(3):273-283. PubMed ID: 28369925
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Pheochromocytoma and Synchronous Neuroblastoma in a Family With Hereditary Pheochromocytoma Associated With a MAX Deleterious Variant.
Duarte DB; Ferreira L; Santos AP; Costa C; Lima J; Santos C; Afonso M; Teixeira MR; Carvalho R; Cardoso MH
Front Endocrinol (Lausanne); 2021; 12():609263. PubMed ID: 33815275
[TBL] [Abstract][Full Text] [Related]
8. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation.
Fujii T; Kawai T; Saito K; Hishima T; Hayashi Y; Imura J; Hironaka M; Hosoya Y; Koike M; Fukayama M
Pathol Int; 1999 Nov; 49(11):968-73. PubMed ID: 10594843
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.
Comino-Méndez I; Gracia-Aznárez FJ; Schiavi F; Landa I; Leandro-García LJ; Letón R; Honrado E; Ramos-Medina R; Caronia D; Pita G; Gómez-Graña A; de Cubas AA; Inglada-Pérez L; Maliszewska A; Taschin E; Bobisse S; Pica G; Loli P; Hernández-Lavado R; Díaz JA; Gómez-Morales M; González-Neira A; Roncador G; Rodríguez-Antona C; Benítez J; Mannelli M; Opocher G; Robledo M; Cascón A
Nat Genet; 2011 Jun; 43(7):663-7. PubMed ID: 21685915
[TBL] [Abstract][Full Text] [Related]
10. Synchronous detection of SDHA-related gallbladder paraganglioma and pancreatic neuroendocrine tumor.
Aaquist T; Medhus JB; Thomassen A; Detlefsen S
Pathol Res Pract; 2020 Jul; 216(7):153006. PubMed ID: 32534711
[TBL] [Abstract][Full Text] [Related]
11. A Novel MAX Gene Mutation Variant in a Patient With Multiple and "Composite" Neuroendocrine-Neuroblastic Tumors.
Pozza C; Sesti F; Di Dato C; Sbardella E; Pofi R; Schiavi F; Bonifacio V; Isidori AM; Faggiano A; Lenzi A; Giannetta E
Front Endocrinol (Lausanne); 2020; 11():234. PubMed ID: 32508744
[No Abstract] [Full Text] [Related]
12. Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway.
Szybowska M; Mete O; Weber E; Silver J; Kim RH
Endocr Pathol; 2019 Sep; 30(3):237-245. PubMed ID: 30772928
[TBL] [Abstract][Full Text] [Related]
13. A novel germline mutation of multiple endocrine neoplasia type 1 (MEN1) gene in a Japanese MEN1 patient and her daughter.
Ohye H; Sato M; Matsubara S; Miyauchi A; Kishi-Imai K; Murao K; Takahara J
Endocr J; 1999 Apr; 46(2):325-9. PubMed ID: 10460018
[TBL] [Abstract][Full Text] [Related]
14. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
15. Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation.
Romanet P; Guerin C; Pedini P; Essamet W; Castinetti F; Sebag F; Roche P; Cascon A; Tischler AS; Pacak K; Barlier A; Taïeb D
Endocr Pathol; 2017 Dec; 28(4):302-307. PubMed ID: 27838885
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
[TBL] [Abstract][Full Text] [Related]
18. No evidence of germline mutation or somatic deletion of the MEN1 gene in a case of familial multiple endocrine neoplasia type 1 (MEN1).
Namihira H; Sato M; Matsubara S; Ohye H; Bhuiyan M; Murao K; Takahara J
Endocr J; 1999 Dec; 46(6):811-6. PubMed ID: 10724357
[TBL] [Abstract][Full Text] [Related]
19. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.
Neychev V; Sadowski SM; Zhu J; Allgaeuer M; Kilian K; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2016 Feb; 101(2):353-8. PubMed ID: 26678657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
